mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.1 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |